Iceland· IS-EU/1/21/1582/001-002
Artesunate Amivas
A artesunate product containing artesunatum inn, registered in Iceland by Amivas Ireland Limited. The same ATC class is registered in 12 of our 19 countries.
Checked against Icelandic Medicines Agency (Iceland) on
Informational only — not a medical device.
Where it is registered
Artesunate is registered in 12 of 19 countries.
Countries holding a registration under ATC P01BE03 (artesunate), each read from that country’s own register.
- This record: Iceland, from Icelandic Medicines Agency (Iceland)
- 7 of them publish a price we can compare per daily dose
Artesunate · ATC P01BE03
12 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- United Kingdom
The record
At a glance
Icelandic Medicines Agency (Iceland)- Active substance
- Artesunatum INN
- Manufacturer
- Amivas Ireland Limited
- Country
- Iceland (IS)
- ATC code
- P01BE03
- ATC class
- Artesunate
- Defined daily dose
- 0.28 g, O
- Reimbursed
- Not published by this register
- Source register
- Icelandic Medicines Agency (Iceland)
- Last checked
- September 29, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
106 interactions on record for artesunate.
Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Artesunate · interactions on record
106 records
- 2 severe
- 104 moderate
Most severe, free to view
- EluxadolineA07DA06severe
- GrazoprevirJ05AP11severe
- RolapitantA04AD14moderate
- EliglustatA16AX10moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Artesunate in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomArtesunate 110mg powder and solvent for solution for injection vialsFlexipharm Austrading Ltd
- BelgiumArtesunate Amivas 110 mgAmivas Ireland
- SpainARTESUNATO AMIVAS 110 MG POLVO Y DISOLVENTE PARA SOLUCION INYECTABLEAmivas Ireland Limited
- NorwayArtesunate AmivasAmivas Ireland Limited
- PolandArtesunate AmivasAmivas Ireland Ltd
- SwedenArtesunate Amivas 110 mg Pulver och vätska till injektionsvätska, lösningAmivas Ireland Limited
- CzechiaARTESUNATE AMIVASAmivas Ireland Ltd, Waterford
- FinlandArtesunate AmivasAmivas Ireland Limited
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Liechtenstein · Artesunate Amivas
- Norway · Artesunate Amivas
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/32583b6d-d5ad-424b-9e3c-0dd6c4d5b550 GET /v1/drugs/32583b6d-d5ad-424b-9e3c-0dd6c4d5b550?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Stungulyfsstofn og leysir, lausn",
"source": "lyfjastofnun",
"atc_raw": "P01BE03",
"marketed": false,
"strength": "110 mg",
"ma_number": "EU/1/21/1582/001-002",
"substance": "Artesunatum INN",
"other_info": null,
"legal_status": "(R) Lyfseðilsskylt\r\n(H) Sjúkrahúsmerkt",
"ma_issued_serial": "44522"
}See everything about artesunate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.